Medical Treatment of Hepatorenal Syndrome - AASLD
Medical Treatment of Hepatorenal Syndrome - AASLD
Medical Treatment of Hepatorenal Syndrome - AASLD
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Survival DistributionFunction1.00.90.80.70.60.50.40.30.20.10.0P-value:Transplant-Free Survival 90 Days0 14(0.875)30(0.477)60(0.991)Survival (Days)= Censored = Terlipressin = Placebo90(0.784)